– IRELAND, Dublin – FBD Holdings plc (LSE:FBH), is pleased to announce the following appointments to take effect immediately.
Mr. Dermot Browne has been appointed as an independent non-executive Director. Mr. Browne is a Fellow of Chartered Accountants Ireland and holds a Bachelor of Commerce degree from University College Galway. Between 2007 and 2011, Mr. Browne held a number of senior executive roles in Aviva Ireland, including the position of CEO with responsibility for all Aviva businesses in Ireland across general insurance, health insurance and life assurance. Prior to this he was a senior executive with Eagle Star Life Assurance Company of Ireland (now Zurich Life) over a sixteen year period with responsibility for finance, sales, marketing and information technology. Between 2012 and 2015 he rejoined Zurich Group in a Global Strategy role based in Switzerland.
Mr. David O’Connor has also been appointed as an independent non-executive Director. Mr. O’Connor is a Fellow of both the Institute of Actuaries and the Society of Actuaries in Ireland. He commenced his career in New Ireland Assurance before joining Allianz Ireland in 1988 to set up its non-life actuarial function. He was a member of Allianz Executive Management Board and held a number of senior management positions there prior to joining Willis Towers Watson in 2003 to set up its Property and Casualty consultancy unit in Dublin.
The Chairman, Mr. Michael Berkery, said: “I am delighted to announce the appointment to the Board of two individuals of the calibre and experience of Mr. Browne and Mr. O’Connor. I am confident that they will add significantly to our Board and I look forward to their contribution.”
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.